至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Development of Multigenic Lentiviral Vectors for Cell-Specific Expression of Antiangiogenic miRNAs and Protein Factors.

Retinal Gene Therapy.. 2018; 
Askou AL, Corydon TJ.
Products/Services Used Details Operation
PCR Cloning and Subcloning … The VMD2 or promotor of choice can be ordered with MluI and SalI flanking sequences from Genscript or other synthetic DNA supplier for subcloning in the pLV/CMV-miR(5, B,7)-PEDF-PE and pLV/CMV-miR(Irr)-PEDF-PE vectors [1]. 1 … Get A Quote

摘要

Generation of lentivirus (LV)-based vectors holding multiple gene cassettes for coexpression of several therapeutic factors provides potent tools in both gene delivery studies as well as in gene therapy. Here we describe the development of such multigenic LV gene delivery vectors enabling cell-specific coexpression of antiangiogenic microRNA (miRNA) and protein factors and, if preferred, a fluorescent reporter, from RNApol(II)-driven expression cassettes orientated in a back-to-back fashion. This configuration may contribute to the development of new combination therapies for amelioration of diseases involving intraocular neovascularization including exudative age-related macular degeneration (AMD).

关键词

AMD; Antiangiogenesis; Cell-specific expression; Coexpression; DNA cloning; Lentivirus; Multigenic vector; Retina; VEGF; miRNA